Status:
NOT_YET_RECRUITING
UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Uterine Sarcoma
Vulvar Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Rare gynecological cancers including uterine sarcomas, vulvar and non-epithelial ovarian cancers, are under-studied diseases and the absence of standardized diagnostic and therapeutic approaches or ta...
Eligibility Criteria
Inclusion
- \>18 years old
- Histological diagnosis of:
- Non-epithelial ovarian tumors Uterine sarcomas Vulvar cancer
Exclusion
- Active HIV, HBV, or HCV infection Synchronous neoplasms Non-rare histologies of gynecological malignancies
Key Trial Info
Start Date :
September 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06582108
Start Date
September 15 2024
End Date
December 31 2026
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli IRCCS
Rome, Italy